Published by Global Banking & Finance Review®
Posted on August 19, 2025
1 min readLast updated: January 22, 2026
Add as preferred source on GoogleMedtronic raises its 2026 profit forecast due to lower tariff impacts, expecting adjusted profits between $5.60-$5.66 per share.
(Reuters) -Medical-device maker Medtronic raised its fiscal 2026 profit forecast on Tuesday and said it expects a smaller-than-expected impact from the tariffs proposed by U.S. President Donald Trump.
The Galway, Ireland-based company expects annual adjusted profit between $5.60 and $5.66 per share, compared with its previous forecast range of $5.50 to $5.60 per share.
Investors have high expectations of medical-device makers, as they continue to benefit from healthy demand for non-urgent surgeries - especially among older Americans - over the last few quarters.
Medtronic trimmed its assumed tariff impact to be about $185 million for the year, versus a previous range of $200 million to $350 million.
(Reporting by Puyaan Singh and Kamal Choudhury in Bengaluru; Editing by Pooja Desai)
Medtronic expects an annual adjusted profit between $5.60 and $5.66 per share, an increase from its previous forecast range of $5.50 to $5.60 per share.
Medtronic has reduced its assumed tariff impact to about $185 million for the year, down from a previous range of $200 million to $350 million.
The demand for medical devices is being driven by healthy demand for non-urgent surgeries, particularly among older Americans, over the last few quarters.
Explore more articles in the Headlines category
